Search Results - "FLATOW, J. L"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II) by ROSOWSKY, A, WRIGHT, J. E, CUCCHI, C. A, FLATOW, J. L, TRITES, D. H, TEICHER, B. A, FREI, E. III

    Published in Cancer research (Chicago, Ill.) (15-11-1987)
    “…A human head and neck squamous cell carcinoma line (SCC25) derived from a patient with no prior history of radiotherapy or chemotherapy was made resistant to…”
    Get full text
    Journal Article
  2. 2

    Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines by TEICHER, B. A, CUCCHI, C. A, LEE, J. B, FLATOW, J. L, ROSOWSKY, A, FREI, E. III

    Published in Cancer research (Chicago, Ill.) (01-09-1986)
    “…The alkylating agents represent one of the most important classes of antitumor agents and play a major role in combination with other agents in the curative…”
    Get full text
    Journal Article
  3. 3

    Combination of N,N',N″-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo by TEICHER, B. A, HOLDEN, S. A, CUCCHI, C. A, CATHCART, K. N. S, KORBUT, T. T, FLATOW, J. L, FREI, E. III

    Published in Cancer research (Chicago, Ill.) (1988)
    “…In vitro and in vivo studies with the drug combination thioTEPA and cyclophosphamide (CPA) were carried out using the MCF-7 human breast carcinoma cell line…”
    Get full text
    Journal Article
  4. 4

    Surgical treatment of complete acromioclavicular dislocations by Weinstein, D M, McCann, P D, McIlveen, S J, Flatow, E L, Bigliani, L U

    Published in The American journal of sports medicine (01-05-1995)
    “…Forty-four patients, ranging in age from 17 to 57 years (average, 32), were evaluated an average of 4 years (range, 2 to 9) after surgical reconstruction for…”
    Get more information
    Journal Article